Part 1 of a four part series on cellular glucose transporters, SGLT1/SGLT2 inhibition, and cellular energetics related to cardiovascular disease and heart failure. This installment gives an overview of the two major cell glucose transporter families - GLUTs and SGLTs - and explains their individual locations, functions, and potential as therapeutic targets.